LON:VEC - Vectura Group Share Price, Forecast & News

Vectura Group trades on the London Stock Exchange (LON) under the ticker symbol "VEC."

Vectura Group announced a dividend on Tuesday, September 10th. Shareholders of record on Monday, October 14th will be paid a dividend of GBX 6 per share on Friday, October 25th. The ex-dividend date of this dividend is Monday, October 14th. The official announcement can be seen at this link. View Vectura Group's Dividend History.

6 brokers have issued 1-year price targets for Vectura Group's shares. Their forecasts range from GBX 114 to GBX 160. On average, they anticipate Vectura Group's stock price to reach GBX 138.50 in the next twelve months. This suggests a possible upside of 50.5% from the stock's current price. View Analyst Price Targets for Vectura Group.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vectura Group in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Vectura Group.

News stories about VEC stock have trended positive this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Vectura Group earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Vectura Group.

Some companies that are related to Vectura Group include Opthea (OPT), Mayne Pharma Group (MYX), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Pharmaxis (PXS), Recce Pharmaceuticals (RCE), Vita Life Sciences (VLS), Futura Medical (FUM), Patrys (PAB), Antisense Therapeutics (ANP), Avivagen (VIV) and Sareum (SAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SkyePharma (SKP), Barratt Developments (BDEV), BP (BP), BTG (BTG), Vesuvius (VSVS), Purplebricks Group (PURP), SINR PHAR/PAR VTG FPD 0.01 (SPH), iRobot (IRBT) and Sirius Minerals (SXX).

Shares of VEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of VEC stock can currently be purchased for approximately GBX 92.

Vectura Group has a market capitalization of £562.58 million and generates £172.30 million in revenue each year. Vectura Group employs 478 workers across the globe.View Additional Information About Vectura Group.

The official website for Vectura Group is http://www.vectura.com/.

Vectura Group's mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The company can be reached via phone at +44-1249-667700.